Skip to main content

Choi elected to National Academy of Medicine

Dr. Augustine M.K. Choi, the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and provost for medical affairs of Cornell University, has been elected to the National Academy of Medicine.

CCE helps Buffalo get school food truck rolling

With help from Cornell Cooperative Extension, the Buffalo City School District unveiled a new Farm to School food truck, which will bring locally-sourced hot food to inner city families.

Intercampus team to develop post-transplant UTI diagnosis

An intercampus research team has been awarded a five-year, $3.65 million grant from the National Institutes of Health to develop a quick, inexpensive method for accurately diagnosing urinary tract infections in kidney transplant patients.

Study upends understanding about joint injuries

A new interdisciplinary study from the College of Veterinary Medicine shows that the protein that lubricates our joints may actually be a signal of impending arthritis in animals and humans.

Smartphone data helps predict schizophrenia relapses

Passive data from smartphones – including movement, ambient sound and sleep patterns – can help predict episodes of schizophrenic relapse, according to new Cornell Tech research.

Ceres2030 offers path to ending world hunger within decade

Small-scale farmers see a path to solving global hunger over the next decade, thanks to a Cornell-hosted project that used artificial intelligence to cull ideas from more than 500,000 scientific research articles.

Weill Cornell Medicine honored again for diversity, inclusion

For the third year in a row, Weill Cornell Medicine has been awarded the Health Professions Higher Education Excellence in Diversity Award by INSIGHT Into Diversity magazine.

CCMR JumpStart program funding three NYS companies

Three New York state companies have been chosen to participate in the Cornell Center for Materials Research JumpStart Program, through which they will collaborate with faculty members to develop and improve their products.

Researchers disrupt signaling pathway to treat colitis

Researchers led by Hening Lin have found a new way to potentially treat inflammatory bowel disease, as well as other autoimmune disorders, by targeting a mechanism that regulates the signaling pathway that enables inflammation to occur.